SCHEMBL8107710

SCHEMBL8107710

O=C1CCN(Cc2c(Cl)cccc2Cl)CC1.O=C1CCN(Cc2c(Cl)cccc2Cl)CC1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2A13 Q16696 3/20 0.61
ALDH1A1 P00352 3/20 0.56
KDM4E B2RXH2 2/20 0.56
POLB P06746 3/20 0.50
NPSR1 Q6W5P4 1/20 0.50
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
OPRM1 P35372 1/20 0.47
OPRD1 P41143 1/20 0.47
OPRK1 P41145 1/20 0.47
OPRL1 P41146 1/20 0.47
COMT P21964 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.43
TSHR P16473 1/20 0.43
ALOX15 P16050 1/20 0.43
TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4882169 1.00 CYP2A13 (0.61) CYP2A13ALDH1A1KDM4EPOLBNPSR1
SCHEMBL4036908 0.84 ALDH1A1 (0.68) CYP2A13ALDH1A1KDM4EPOLBNPSR1
SCHEMBL8108285 0.80 SIGMAR1 (0.64) CYP2A13ALDH1A1KDM4ENPSR1KMT2A
SCHEMBL5675319 0.80 SIGMAR1 (0.64) CYP2A13ALDH1A1KDM4ENPSR1KMT2A
SCHEMBL30596550 0.79 KDM4E (0.70) CYP2A13ALDH1A1KDM4EPOLBMEN1
SCHEMBL6941394 0.77 CYP2A13 (0.56) CYP2A13ALDH1A1KDM4EPOLBNPSR1
SCHEMBL3966949 0.76 CYP2A13 (0.62) CYP2A13ALDH1A1KDM4EPOLBNPSR1
SCHEMBL4097834 0.76 CYP2A13 (1.00) CYP2A13ALDH1A1KDM4EMEN1KMT2A
SCHEMBL2306473 0.76 CYP2A13 (0.62) CYP2A13ALDH1A1KDM4EPOLBMEN1
SCHEMBL4109734 0.76 CYP2A13 (0.62) CYP2A13ALDH1A1KDM4EPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056744-A1 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES Aventis Pharmaceuticals Inc. (US) 2000-12-06 EP disclosed
WO-1999043675-A1 6,9-DISUBSTITUTED 2-[TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES AVENTIS PHARMACEUTICALS INC. (US) 1999-09-02 WO disclosed